Devang Vallabhdas Kantesaria
Directeur Général chez Valley Forge Capital Management LP
Profil
Devang Vallabhdas Kantesaria is currently a Principal at Valley Forge Capital Management LP.
He previously worked as an Independent Director at Inotek Pharmaceuticals Corp., and as a Director at Agile Therapeutics, Inc., Ventaira Pharmaceuticals, Inc., and Diasome Pharmaceuticals, Inc. He was also a Principal at TL Ventures, Inc. and a General Partner at Devon Park Bioventures.
Dr. Kantesaria received his undergraduate degree from Massachusetts Institute of Technology and his doctorate from Harvard Medical School.
Postes actifs de Devang Vallabhdas Kantesaria
| Sociétés | Poste | Début |
|---|---|---|
Valley Forge Capital Management LP
 Valley Forge Capital Management LP Investment ManagersFinance Valley Forge Capital Management LP (VFCM) is an independent, SEC-registered investment advisor and hedge fund manager headquartered in Wayne, Pennsylvania. The firm was founded by Devang Kantesaria in 2009 as Valley Forge Advisors LP, the successor entity to Valley Forge Advisors LLC. VFCM provides advisory services on a discretionary basis to privately offered pooled investment vehicles, which are intended for investment by certain investors that are accredited investors as defined under federal securities law. | Directeur Général | - |
Anciens postes connus de Devang Vallabhdas Kantesaria
| Sociétés | Poste | Fin |
|---|---|---|
Devon Park Bioventures
 Devon Park Bioventures Investment ManagersFinance Devon Park Bioventures (Devon Park Bioventures) is a venture capital firm founded in 2006. The firm is headquartered in Pennsylvania, United States. | Private Equity Investor | 31/12/2017 |
Inotek Pharmaceuticals Corp.
 Inotek Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Inotek Pharmaceuticals Corp. is a clinical-stage biopharmaceutical company. It focuses on the discovery, development and commercialization of therapies for glaucoma and other diseases of the eye. The company's product candidate includes Trabodenoson, an adenosine mimetic that has completed Phase II clinical trials for lowering IOP by restoring the eye's natural pressure control mechanism. It is also developing Trabodenoson plus Latanoprost, a prostaglandin analogue that has completed Phase II clinical trials for use in patients with inadequate responses to treatment with latanoprost; and Trabodenoson monotherapy for the treatment of optic nerve neuropathy. Inotek Pharmaceuticals was founded on July 7, 1999 by Csaba Szabo and Andrew L. Salzman and is headquartered in Lexington, MA. | Directeur/Membre du Conseil | 24/06/2015 |
TL Ventures, Inc.
 TL Ventures, Inc. Investment ManagersFinance TL Ventures Inc (TL Ventures) is a venture capital subsidiary of Safeguard Scientifics, Inc. founded in 1988 by Robert Keith. The firm is headquartered in Wayne, Pennsylvania. | Private Equity Investor | 30/04/2008 |
Diasome Pharmaceuticals, Inc.
 Diasome Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Diasome Pharmaceuticals, Inc. operates as a clinical stage diabetes therapeutics company which designs and develops insulin-based therapies for the treatment of diabetes. It focuses on the clinical and commercial development of breakthrough therapies for diabetes and obesity. The company’s technology platform is based on the use of its proprietary Hepatocyte Directed Vesicle or HDV, nanotechnology to deliver a wide range of critically necessary hormones and drugs to the liver, the body’s primary site of glucose storage. The firm’s HDV system is designed to fundamentally improve the way in which insulin works in people with diabetes by enabling much greater amounts of injected insulin to reach hepatocytes, the liver’s glucose storing cells. The company was founded by Len Rosenberg, Lance Converse, W. Blair Geho and Robert Geho in 2004 and is headquartered in Cleveland, OH. | Directeur/Membre du Conseil | - |
McKinsey & Co., Inc.
 McKinsey & Co., Inc. Miscellaneous Commercial ServicesCommercial Services McKinsey & Co., Inc. provides management consulting services. It specializes in design, marketing and sales, analytics, operations, transformation and restructuring, risk, strategy and corporate finance, and sustainability and resource productivity. The company was founded by James O. McKinsey in 1926 and is headquartered in New York, NY. | Corporate Officer/Principal | - |
Formation de Devang Vallabhdas Kantesaria
| Massachusetts Institute of Technology | Undergraduate Degree |
| Harvard Medical School | Doctorate Degree |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| AGILE THERAPEUTICS, INC. | Health Technology |
| Entreprise privées | 7 |
|---|---|
TL Ventures, Inc.
TL Ventures, Inc. Investment ManagersFinance TL Ventures Inc (TL Ventures) is a venture capital subsidiary of Safeguard Scientifics, Inc. founded in 1988 by Robert Keith. The firm is headquartered in Wayne, Pennsylvania. | Finance |
Ventaira Pharmaceuticals, Inc.
 Ventaira Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Ventaira Pharmaceuticals Inc. develops aerosol devices. It offers inhaled drugs, including fentanyl for the treatment of breakthrough pain and salmeterol/flucticasone for asthma. The company was founded in April 2000 and is headquartered in Columbus, OH. | Health Technology |
McKinsey & Co., Inc.
McKinsey & Co., Inc. Miscellaneous Commercial ServicesCommercial Services McKinsey & Co., Inc. provides management consulting services. It specializes in design, marketing and sales, analytics, operations, transformation and restructuring, risk, strategy and corporate finance, and sustainability and resource productivity. The company was founded by James O. McKinsey in 1926 and is headquartered in New York, NY. | Commercial Services |
Devon Park Bioventures
Devon Park Bioventures Investment ManagersFinance Devon Park Bioventures (Devon Park Bioventures) is a venture capital firm founded in 2006. The firm is headquartered in Pennsylvania, United States. | Finance |
Diasome Pharmaceuticals, Inc.
Diasome Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Diasome Pharmaceuticals, Inc. operates as a clinical stage diabetes therapeutics company which designs and develops insulin-based therapies for the treatment of diabetes. It focuses on the clinical and commercial development of breakthrough therapies for diabetes and obesity. The company’s technology platform is based on the use of its proprietary Hepatocyte Directed Vesicle or HDV, nanotechnology to deliver a wide range of critically necessary hormones and drugs to the liver, the body’s primary site of glucose storage. The firm’s HDV system is designed to fundamentally improve the way in which insulin works in people with diabetes by enabling much greater amounts of injected insulin to reach hepatocytes, the liver’s glucose storing cells. The company was founded by Len Rosenberg, Lance Converse, W. Blair Geho and Robert Geho in 2004 and is headquartered in Cleveland, OH. | Health Technology |
Inotek Pharmaceuticals Corp.
Inotek Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Inotek Pharmaceuticals Corp. is a clinical-stage biopharmaceutical company. It focuses on the discovery, development and commercialization of therapies for glaucoma and other diseases of the eye. The company's product candidate includes Trabodenoson, an adenosine mimetic that has completed Phase II clinical trials for lowering IOP by restoring the eye's natural pressure control mechanism. It is also developing Trabodenoson plus Latanoprost, a prostaglandin analogue that has completed Phase II clinical trials for use in patients with inadequate responses to treatment with latanoprost; and Trabodenoson monotherapy for the treatment of optic nerve neuropathy. Inotek Pharmaceuticals was founded on July 7, 1999 by Csaba Szabo and Andrew L. Salzman and is headquartered in Lexington, MA. | Health Technology |
Valley Forge Capital Management LP
Valley Forge Capital Management LP Investment ManagersFinance Valley Forge Capital Management LP (VFCM) is an independent, SEC-registered investment advisor and hedge fund manager headquartered in Wayne, Pennsylvania. The firm was founded by Devang Kantesaria in 2009 as Valley Forge Advisors LP, the successor entity to Valley Forge Advisors LLC. VFCM provides advisory services on a discretionary basis to privately offered pooled investment vehicles, which are intended for investment by certain investors that are accredited investors as defined under federal securities law. | Finance |